Michael J. Cavnar

1.7k total citations · 1 hit paper
52 papers, 1.2k citations indexed

About

Michael J. Cavnar is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael J. Cavnar has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Gastroenterology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael J. Cavnar's work include Gastrointestinal Tumor Research and Treatment (16 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Gastric Cancer Management and Outcomes (8 papers). Michael J. Cavnar is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (16 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Gastric Cancer Management and Outcomes (8 papers). Michael J. Cavnar collaborates with scholars based in United States, Canada and Netherlands. Michael J. Cavnar's co-authors include Ronald P. DeMatteo, Vinod P. Balachandran, Cristina R. Antonescu, Lee M. Ocuin, Shan Zeng, Zubin M. Bamboat, Eric C. Sorenson, Rachel Popow, Ferdinand Rossi and Peter Besmer and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Michael J. Cavnar

46 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

2011 410 citations Vinod P. Balachandran, Michael J. Cavnar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Cavnar United States	17	502	426	334	326	248	52	1.2k
Yuyong Tan China	23	674 1.3×	319 0.7×	745 2.2×	730 2.2×	813 3.3×	130	2.3k
Yunpeng Liu China	20	501 1.0×	179 0.4×	98 0.3×	454 1.4×	167 0.7×	78	1.3k
Liangliang Wu China	18	337 0.7×	179 0.4×	81 0.2×	330 1.0×	202 0.8×	67	1.0k
Fangxuan Li China	23	423 0.8×	276 0.6×	58 0.2×	326 1.0×	193 0.8×	55	1.3k
Ru Jia China	19	833 1.7×	415 1.0×	36 0.1×	318 1.0×	159 0.6×	50	1.6k
Hisahiro Hosogi Japan	18	638 1.3×	246 0.6×	226 0.7×	563 1.7×	484 2.0×	58	1.4k
Zhiwei Zhou China	17	398 0.8×	123 0.3×	50 0.1×	288 0.9×	152 0.6×	53	997
Hidenori Akaike Japan	14	579 1.2×	395 0.9×	48 0.1×	265 0.8×	228 0.9×	83	1.0k
Jiren Yu China	19	352 0.7×	205 0.5×	132 0.4×	311 1.0×	230 0.9×	56	960
Shusaku Tsutsui Japan	23	306 0.6×	102 0.2×	482 1.4×	625 1.9×	697 2.8×	65	1.6k

Countries citing papers authored by Michael J. Cavnar

Since Specialization

Citations

This map shows the geographic impact of Michael J. Cavnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Cavnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Cavnar more than expected).

Fields of papers citing papers by Michael J. Cavnar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Cavnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Cavnar. The network helps show where Michael J. Cavnar may publish in the future.

Co-authorship network of co-authors of Michael J. Cavnar

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Cavnar. A scholar is included among the top collaborators of Michael J. Cavnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Cavnar. Michael J. Cavnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Merkow, Ryan P., Michael J. Cavnar, Ana Gleisner, et al.. (2025). Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective. Annals of Surgical Oncology. 32(6). 4408–4416.

Grünhagen, Dirk J., Ryan P. Merkow, Michael J. Cavnar, et al.. (2025). The Landmark Series: Hepatic Arterial Infusion Pump Chemotherapy for Colorectal Liver Metastases and Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 32(12). 9138–9145.

Zhang, Shulin, Nan Lin, E Belcher, et al.. (2024). Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. JCO Precision Oncology. 8(8). e2300266–e2300266. 1 indexed citations

Kennedy, Andrew, Erin E. Burke, Michael J. Cavnar, et al.. (2024). Development of a Novel Protocol for Germline Testing in Pancreatic Cancer. Annals of Surgical Oncology. 31(12). 7705–7712. 3 indexed citations

Hill, Kristen S., Charles J. Bailey, Michael J. Cavnar, et al.. (2023). Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses. Cancers. 15(11). 3036–3036. 4 indexed citations

Wright, Matthew, Rani Jayswal, Heidi L. Weiss, et al.. (2023). Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers. Annals of Surgical Oncology. 31(2). 1252–1263. 2 indexed citations

Hedges, D.J., Matthew J. Reilley, Susanna V. Ulahannan, et al.. (2023). Molecular Subtypes and Outcomes in a Multi-Institutional Review of Rectal Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 117(2). e306–e307. 1 indexed citations

Shah, Malay B., Meera Gupta, Francesc Martí, et al.. (2023). Liver transplantation for biliary cysts: perioperative and long-term outcomes. HPB. 25(8). 954–961.

Cavnar, Michael J., et al.. (2022). Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells. PLoS ONE. 17(7). e0270832–e0270832. 6 indexed citations

10.

Cavnar, Michael J., Michael E. Lidsky, Ismael Domínguez-Rosado, et al.. (2022). Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network. HPB. 24(12). 2104–2111. 14 indexed citations

11.

Burke, Erin E., et al.. (2022). The Development of Investigator-Initiated Clinical Trials in Surgical Oncology. Surgical Oncology Clinics of North America. 32(1). 13–25. 3 indexed citations

12.

Ecker, Brett L., Robert G. Maki, Michael J. Cavnar, & Ronald P. DeMatteo. (2020). Surgical Management of Sarcoma Metastatic to Liver. Surgical Oncology Clinics of North America. 30(1). 57–67. 5 indexed citations

13.

Cavnar, Michael J., Kenneth Seier, Mithat Gönen, et al.. (2020). Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor. Journal of Gastrointestinal Surgery. 25(7). 1828–1836. 13 indexed citations

14.

Medina, Benjamin D., Mengyuan Liu, Gerardo A. Vitiello, et al.. (2019). Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity. The Journal of Experimental Medicine. 216(6). 1359–1376. 22 indexed citations

15.

Zeng, Shan, Adrian M. Seifert, Jennifer Q. Zhang, et al.. (2017). Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 16(9). 1954–1966. 31 indexed citations

16.

Vitiello, Gerardo A., Michael J. Cavnar, Cristina Hajdu, et al.. (2017). Minimally Invasive Management of Ectopic Pancreas. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(3). 277–282. 14 indexed citations

17.

Sorenson, Eric C., Raya Khanin, Zubin M. Bamboat, et al.. (2017). Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation. PLoS ONE. 12(5). e0176562–e0176562. 23 indexed citations

18.

Kim, Teresa S., Michael J. Cavnar, Noah A. Cohen, et al.. (2014). Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor. Clinical Cancer Research. 20(9). 2350–2362. 44 indexed citations

19.

Cavnar, Michael J., Shan Zeng, Teresa S. Kim, et al.. (2013). KIT oncogene inhibition drives intratumoral macrophage M2 polarization. The Journal of Experimental Medicine. 210(13). 2873–2886. 101 indexed citations

20.

Pérez, Daniel, Raymond E. Baser, Michael J. Cavnar, et al.. (2012). Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor. Annals of Surgical Oncology. 20(2). 593–599. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact